Tech Company Financing Transactions
CTIBIOTECH Funding Round
CTIBIOTECH, based in Lyon, raised $1.5 million in investment from Bpifrance.
Transaction Overview
Company Name
Announced On
4/28/2026
Transaction Type
Venture Equity
Amount
$1,500,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its R&D efforts to launch the �2.46M CTIONCOTEST� project.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Bat A16, 5 avenue Lionel Terray, Meyzieu
Lyon, 69330
France
Lyon, 69330
France
Phone
Undisclosed
Website
Email Address
Overview
CTIBIOTECH is a pioneering company based in Lyon (France) and Philadelphia, USA, specializing in the development of advanced human tissues for biomedical research and the pharmaceutical industry, and for future therapies. Founded in 2009, CTIBIOTECH revolutionizes research and development of new treatments by providing alternative solutions to animal testing with humanized systems. More than 30 countries use our tissues. At CTIBIOTECH, we believe in innovation for a healthier future. Our goal is to create accurate and reliable human tissues that enable researchers and companies to better understand diseases, test drugs, and develop new treatments. We use cutting-edge technologies, such as stem cells and 3D printing, to create 3D tissue and cell models that realistically simulate the structure and function of human tissues.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nico Forraz
Browse more venture capital transactions:
Prev: 4/28/2026: Snabbit venture capital transaction
Next: 4/28/2026: Cnuic Technologies venture capital transaction
Share this article
Where The Data Comes From
We document funding rounds that are announced publicly. VC transactions on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs